The latest financial statement is for the year ending 2025-12-31.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -1,220.4 |
| Less income from discontinued operations, net of tax | -559.9 |
| Loss from continuing operations | -1,780.3 |
| Gain on disposition of discontinued operations | 5,263.4 |
| Provision for bad debt | 7.3 |
| Provision for inventory reserves | -757.4 |
| Depreciation and amortization | 610 |
| Impairment of intangible assets | 291.6 |
| Stock-based compensation | 520.7 |
| (gain) loss on sale of investment securities | 20.1 |
| Unrealized holding loss (gain) on investment securities | -2.4 |
| Noncash lease expense | 257.1 |
| Trade accounts receivable | 291.2 |
| Inventories | 682.1 |
| Prepaid expense and other current assets | 791.1 |
| Income tax receivable | 0 |
| Other assets | -24.8 |
| Accounts payable | 166.4 |
| Accrued expenses | -212.4 |
| Contract liabilities | 36.3 |
| Lease liabilities | -268.2 |
| Net cash used in operating activities | -8,149.6 |
| Redemption of investment securities | 3,745.7 |
| Purchase of investment securities | 7,465.7 |
| Proceeds from disposition of discontinued operations | 7,614.2 |
| Capital expenditures | 63.2 |
| Net cash provided by investing activities | 3,831 |
| Proceeds from issuance of common stock | 2,050 |
| Issuance cost of common stock and warrants | 97.8 |
| Net cash provided by financing activities | 1,952.2 |
| Net cash provided by (used in) operating activities of discontinued operations | 2,694.8 |
| Net change in cash | 328.4 |
| Effect of changes in foreign currency exchange rates on cash and cash equivalents | 38.7 |
| Cash and cash equivalents, beginning of year | 587.9 |
| Cash from discontinued operations beginning of year | 0 |
| Less cash from discontinued operations end of year | 0 |
| Cash and cash equivalents, end of year | 955 |
SCIENTIFIC INDUSTRIES INC (SCND)
SCIENTIFIC INDUSTRIES INC (SCND)